• Ferroptosis synergistically sensitizes wee1 inhibitors: a bibliometric study.
    • Xu R, Wu X, Zhao Q, Yang Q.
    • Am J Transl Res. 2022 Dec 15;14(12):8473-8488.
    • Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders.
    • Carrasco E, López-Fernández A, Codina-Sola M, Valenzuela I, Cueto-González AM, Villacampa G, Navarro V, Torres-Esquius S, Palau D, Cruellas M, Torres M, Perez-Dueñas B, Abulí A, Diez O, Sábado-Álvarez C, García-Arumí E, Tizzano EF, Moreno L, Balmaña J.
    • J Med Genet. 2022 Nov 29:jmg-2022-108929. doi: 10.1136/jmg-2022-108929. Epub ahead of print.
    • How should we address the inevitable harms from non-negligent variant reclassification in predictive genetic testing?
    • Rashkin M, Kingham K, Lara-Otero K, Mckenna M, Villiers J, Worthington MM, Prince A.
    • J Genet Couns. 2022 Oct 19. doi: 10.1002/jgc4.1638. Epub ahead of print.
    • Genetic Testing Challenges in Oncology: Missed Variant Update Delays Li-Fraumeni Diagnosis.
    • Ray T.
    • Precision Oncology News. 2022 Oct 12.

    Related:

    Special article:

    Is there a duty to reinterpret genetic data? The ethical dimensions.

    • Developing theory-driven narrative messages with personal stories: A step-by-step guide.
    • Conley CC, Davidson LG, Scherr CL, Dean M.
    • Psychooncology. 2022 Oct 7. doi: 10.1002/pon.6047. Epub ahead of print.
    • A bibliometric analysis of the top 100 most cited papers and research trends in breast cancer related BRCA1 and BRCA2 genes.
    • Alkhayyat S, Khan M, Ahmad T, Haroon, Tariq H, Baig M.
    • Medicine (Baltimore). 2022 Sep 23;101(38):e30576. doi: 10.1097/MD.0000000000030576.
    • Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK).
    • Loong L, Garrett A, Allen S, Choi S, Durkie M, Callaway A, Drummond J, Burghel GJ, Robinson R, Torr B, Berry IR, Wallace AJ, Eccles DM, Ellard S, Baple E, Evans DG, Woodward ER, Kulkarni A, Lalloo F, Tischkowitz M, Lucassen A, Hanson H, Turnbull C; CanVIG-UK.
    • Genet Med. 2022 Sep;24(9):1867-1877. doi: 10.1016/j.gim.2022.05.002. Epub 2022 Jun 3.
    • BRCA testing on buccal swab to improve access to healthcare and cancer prevention: a performance evaluation.
    • De Paolis E, Perrucci A, Marchetti C, Pietragalla A, Scambia G, Urbani A, Fagotti A, Minucci A.
    • Int J Gynecol Cancer. 2022 Aug 26:ijgc-2022-003718. doi: 10.1136/ijgc-2022-003718. Epub ahead of print.
    • Counting the cost of public and philanthropic R&D funding: the case of olaparib.
    • Schmidt L, Sehic O, Wild C.
    • J Pharm Policy Pract. 2022 Aug 16;15(1):47. doi: 10.1186/s40545-022-00445-9.
    • Somatic DNA Damage Response and Homologous Repair Gene Alterations and Its Association With Tumor Variant Burden in Breast Cancer Patients With Occupational Exposure to Pesticides.
    • Scandolara TB, Valle SF, Teixeira CE, Scherer NM, de Armas EM, Furtado C, Boroni M, Jaques HDS, Alves FM, Rech D, Panis C, Bonvicino CR.
    • Front Oncol. 2022 Jul 8;12:904813. doi: 10.3389/fonc.2022.904813.
    • Outcomes of retesting in patients with previously uninformative cancer genetics evaluations.
    • Dettwyler SA, Koeppe ES, Jacobs MF, Stoffel EM.
    • Fam Cancer. 2022 Jul;21(3):375-385. doi: 10.1007/s10689-021-00276-8. Epub 2021 Sep 21. Erratum in: Fam Cancer. 2021 Oct 28.
    • What Chris Evert’s Story Can Teach the World about Genetic Testing.
    • Matloff ET.
    • FORCE. Blog. 2022 Jun 22.
    • Medicaid Expansions: Probing Medicaid's Filling of the Cancer Genetic Testing and Screening Space.
    • Modell SM, Schlager L, Allen CG, Marcus G.
    • Healthcare (Basel). 2022 Jun 8;10(6):1066. doi: 10.3390/healthcare10061066.
    • Exploring the diagnostic utility of genome sequencing for fetal congenital heart defects.
    • Cao Y, Chau MHK, Zheng Y, Zhao Y, Kwan AHW, Hui SYA, Lam YH, Tan TYT, Tse WT, Wong L, Leung TY, Dong Z, Choy KW.
    • Prenat Diagn. 2022 Jun;42(7):862-872. doi: 10.1002/pd.6151. Epub 2022 Apr 27.
    • Development of a clinical polygenic risk score assay and reporting workflow.
    • Hao L, Kraft P, Berriz GF, Hynes ED, Koch C, Korategere V Kumar P, Parpattedar SS, Steeves M, Yu W, Antwi AA, Brunette CA, Danowski M, Gala MK, Green RC, Jones NE, Lewis ACF, Lubitz SA, Natarajan P, Vassy JL, Lebo MS.
    • Nat Med. 2022 May;28(5):1006-1013. doi: 10.1038/s41591-022-01767-6. Epub 2022 Apr 18.

    Related:

    Research news: Clinical Polygenic Risk Assay, Reporting Pipeline Shows Promise for Multiple Conditions. (GenomeWeb)

    Research news: New PRS for Six Common Diseases to Aid Patient, Physician Healthcare Decisions. (Inside Precision Medicine)

    • Cancer Causative Mutations Occurring in Early Embryogenesis.
    • Pareja F, Ptashkin RN, Brown DN, Derakhshan F, Selenica P, da Silva EM, Gazzo AM, Da Cruz Paula A, Breen K, Shen R, Marra A, Zehir A, Benayed R, Berger MF, Ceyhan-Birsoy O, Jairam S, Sheehan M, Patel U, Kemel Y, Casanova-Murphy J, Schwartz CJ, Vahdatinia M, Comen E, Borsu L, Pei X, Riaz N, Abramson DH, Weigelt B, Walsh MF, Hadjantonakis AK, Ladanyi M, Offit K, Stadler ZK, Robson ME, Reis-Filho JS, Mandelker D.
    • Cancer Discov. 2022 Apr 1;12(4):949-957. doi: 10.1158/2159-8290.CD-21-1110.

    Related:

    Commentary:

    Patchwork Cancer Predisposition.

    • Opinions and experiences of recontacting patients: a survey of Australasian genetic health professionals.
    • Vora BB, Mountain H, Nichols C, Schofield L.
    • J Community Genet. 2022 Apr;13(2):193-199. doi: 10.1007/s12687-021-00570-z. Epub 2022 Jan 11.
    • Human BRCA pathogenic variants were originated during recent human history.
    • Li J, Zhao B, Huang T, Qin Z, Wang SM.
    • Life Sci Alliance. 2022 Feb 14;5(5):e202101263. doi: 10.26508/lsa.202101263.
    • Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study.
    • Meiser B, Monnik M, Austin R, Nichols C, Cops E, Salmon L, Spurdle AB, Macrae F, Taylor N, Pachter N, James P, Kaur R.
    • J Community Genet. 2022 Feb;13(1):59-73. doi: 10.1007/s12687-021-00559-8. Epub 2021 Nov 2.
    • [2. Paradigm Shift from the Experiences of Hereditary Breast Cancer].
    • Yamauchi H.
    • Nihon Hoshasen Gijutsu Gakkai Zasshi. 2022;78(5):531-534. Japanese. doi: 10.6009/jjrt.2022-2022.
    • [Article in Japanese]
    • HerediCaRe: Dokumentations- und IT-Lösung eines spezialisierten Registers für erblichen Brust- und Eierstockkrebs [HerediCaRe: Documentation and IT Solution of a Specialized Registry for Hereditary Breast and Ovarian Cancer].
    • Engel C, Wieland K, Zachariae S, Bucksch K, Enders U, Schoenwiese U, Yahiaoui-Doktor M, Keupp K, Waha A, Hahnen E, Remy R, Ernst C, Loeffler M, Schmutzler RK.
    • Gesundheitswesen. 2021 Nov;83(S 01):S12-S17. German. doi: 10.1055/a-1658-0313. Epub 2021 Nov 3.
    • Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification.
    • Fridman AL, Raz A, Timmermans S, Shkedi-Rafid S.
    • J Community Genet. 2021 Oct 5:1–6. doi: 10.1007/s12687-021-00556-x. Epub ahead of print.
    • Liquid Biopsy Can Detect Brca2 Gene Variants In Female Dogs With Mammary Neoplasia.
    • de Oliveira JR, Colombo J, Gonçalves FM, de Carvalho LAL, Costa DS, Henrique T, Novais AA, Moscheta-Pinheiro MG, de Almeida Chuffa LG, Coutinho LL, Santana ÁE, de Campos Zuccari DAP.
    • Vet Comp Oncol. 2021 Jul 30. doi: 10.1111/vco.12758. Epub ahead of print.
    • Challenges to Building a Gene Variant Commons to Assess Hereditary Cancer Risk: Results of a Modified Policy Delphi Panel Deliberation.
    • Majumder MA, Blank ML, Geary J, Bollinger JM, Guerrini CJ, Robinson JO, Canfield I, Cook-Deegan R, McGuire AL.
    • J Pers Med. 2021 Jul 8;11(7):646. doi: 10.3390/jpm11070646.
    • Tracing ovarian cancer research in Morocco: A bibliometric analysis.
    • El Bairi K, Al Jarroudi O, Afqir S.
    • Gynecol Oncol Rep. 2021 May 7;37:100777. doi: 10.1016/j.gore.2021.100777.
    • One of the Biggest Healthcare Frauds Ever Is Still Ongoing — Cancer Genetic Testing Scams.
    • Mulcahy N.
    • Medscape Oncology. 2021 May 4.
    • Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?
    • Fresa A, Sica S.
    • Hered Cancer Clin Pract. 2021 Apr 1;19(1):22. doi: 10.1186/s13053-021-00179-w.
    • Estimation of healthcare-related charges in women with BRCA mutations and breast cancer.
    • Biskupiak J, Unni S, Telford C, Yoo M, Ye X, Deka R, Brixner D, Stenehjem D.
    • BMC Health Serv Res. 2021 Jan 13;21(1):58. doi: 10.1186/s12913-020-06038-z.
    • My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe.
    • [No author given]
    • My Gene Counsel. Press Releases. 2020 Dec 29.
    • My Gene Counsel, Genomet Develop Decision Support Solution for Precision Cancer Care.
    • [No author given]
    • Precision Oncology News. 2020 Dec 29.
    • Group Therapy for Patients With Medical Illness.
    • Leszcz M.
    • Am J Psychother. 2020 Oct 22:appipsychotherapy20200005. doi: 10.1176/appi.psychotherapy.20200005. Epub ahead of print.
    • Ethical challenges of precision cancer medicine.
    • Winkler EC, Knoppers BM.
    • Semin Cancer Biol. 2020 Oct 9:S1044-579X(20)30201-7. doi: 10.1016/j.semcancer.2020.09.009. Epub ahead of print.
    • Review
    • Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
    • Green RF, Kumerow MT, Rodriguez JL, Addie S, Beachy SH, Senier L.
    • Public Health Genomics. 2020 Sep 17:1-12. doi: 10.1159/000510336. Epub ahead of print.

    Related:

    Original research:

    Proposed outcomes measures for state public health genomic programs.

    • Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial.
    • Pace LE, Lee YS, Tung N, Hamilton JG, Gabriel C, Raja SC, Jenkins C, Braswell A, Domchek SM, Symecko H, Spielman K, Karlan BY, Lester J, Kamara D, Levin J, Morgan K, Offit K, Garber J, Keating NL.
    • BMC Med Res Methodol. 2020 Aug 17;20(1):210. doi: 10.1186/s12874-020-01086-9.
    • Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.
    • Roman TS, Crowley SB, Roche MI, Foreman AKM, O'Daniel JM, Seifert BA, Lee K, Brandt A, Gustafson C, DeCristo DM, Strande NT, Ramkissoon L, Milko LV, Owen P, Roy S, Xiong M, Paquin RS, Butterfield RM, Lewis MA, Souris KJ, Bailey DB Jr, Rini C, Booker JK, Powell BC, Weck KE, Powell CM, Berg JS.
    • Am J Hum Genet. 2020 Aug 14:S0002-9297(20)30269-X. doi: 10.1016/j.ajhg.2020.08.001. Epub ahead of print.
    • Framing Ethical Concerns and Attitudes towards Human Gene Patents in the Chinese Press.
    • Du L, Lin S, Kamenova K.
    • Asian Bioeth Rev. 2020 Aug 1;12(3):307-323. doi: 10.1007/s41649-020-00136-0.
    • Special bioactive compounds and functional foods may exhibit neuroprotective effects in patients with dementia (Review).
    • Murakami M, Ikeda Y, Nakagawa Y, Tsuji A, Kitagishi Y, Matsuda S.
    • Biomed Rep. 2020 Aug;13(2):1. doi: 10.3892/br.2020.1310. Epub 2020 Jun 2.
    • Natural Selection Shapes Codon Usage in the Human Genome.
    • Dhindsa RS, Copeland BR, Mustoe AM, Goldstein DB.
    • Am J Hum Genet. 2020 Jun 1:S0002-9297(20)30158-0. doi: 10.1016/j.ajhg.2020.05.011. Epub ahead of print.
    • Genetic Protection Modifications: Moving Beyond the Binary Distinction Between Therapy and Enhancement for Human Genome Editing.
    • Mikkelsen RB, Frederiksen HRS, Gjerris M, Holst B, Hyttel P, Luo Y, Freude K, Sandøe P.
    • CRISPR J. 2019 Dec;2(6):362-369. doi: 10.1089/crispr.2019.0024.
    • Commentary
    • The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective.
    • Sidorenkov G, Nagel J, Meijer C, Duker JJ, Groen HJM, Halmos GB, Oonk MHM, Oostergo RJ, van der Vegt B, Witjes MJH, Nijland M, Havenga K, Maduro JH, Gietema JA, de Bock GH.
    • J Transl Med. 2019 Nov 14;17(1):374. doi: 10.1186/s12967-019-2122-x.
    • BRCA1 regulates HMGA2 levels in the Swan71 trophoblast cell line.
    • West RC, Russ JE, Bouma GJ, Winger QA.
    • Mol Reprod Dev. 2019 Aug 13. doi: 10.1002/mrd.23255. [Epub ahead of print]
    • BRCA1 and BRCA2 Gene Expression: Diurnal Variability and Influence of Shift Work.
    • Bracci M, Ciarapica V, Zabaleta ME, Tartaglione MF, Pirozzi S, Giuliani L, Piva F, Valentino M, Ledda C, Rapisarda V, Stevens RG, Santarelli L.
    • Cancers (Basel). 2019 Aug 9;11(8). pii: E1146. doi: 10.3390/cancers11081146.
    • Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    • Rasnic R, Brandes N, Zuk O, Linial M.
    • BMC Cancer. 2019 Aug 7;19(1):783. doi: 10.1186/s12885-019-5994-5.
    • Targeted short read sequencing and assembly of re-arrangements and candidate gene loci provide megabase diplotypes.
    • Shin G, Greer SU, Xia LC, Lee H, Zhou J, Boles TC, Ji HP.
    • Nucleic Acids Res. 2019 Jul 27. pii: gkz661. doi: 10.1093/nar/gkz661. [Epub ahead of print]
    • Hospital apologises to woman given wrong test result for breast cancer gene.
    • [No author given]
    • The Irish Times. 2019 May 29.
    • Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Recruitment Efforts for Population-Based Studies.
    • Millar MM, Kinney AY, Camp NJ, Cannon-Albright LA, Hashibe M, Penson DF, Kirchhoff AC, Neklason DW, Gilsenan AW, Dieck GS, Stroup AM, Edwards SL, Bateman C, Carter ME, Sweeney C.
    • Am J Epidemiol. 2019 May 1;188(5):928-939. doi: 10.1093/aje/kwz011.
    • Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health medicine.
    • Gripsrud BH, Solbrække KN.
    • Med Health Care Philos. 2019 Apr 25. doi: 10.1007/s11019-019-09901-x. [Epub ahead of print]

    Related:

    Commentary:

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    • Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report.
    • Spurdle AB, Greville-Heygate S, Antoniou AC, Brown M, Burke L, de la Hoya M, Domchek S, Dörk T, Firth HV, Monteiro AN, Mensenkamp A, Parsons MT, Radice P, Robson M, Tischkowitz M, Tudini E, Turnbull C, Vreeswijk MP, Walker LC, Tavtigian S, Eccles DM.
    • J Med Genet. 2019 Apr 8. pii: jmedgenet-2018-105872. doi: 10.1136/jmedgenet-2018-105872. [Epub ahead of print]
    • Review, Guidelines
    • Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.
    • Vos JR, Giepmans L, Röhl C, Geverink N, Hoogerbrugge N; ERN GENTURIS.
    • Fam Cancer. 2019 Apr;18(2):281-284. doi: 10.1007/s10689-018-0110-6.
    • Ambry and My Gene Counsel Team Up on Tests to Confirm DTC Results, Counseling.
    • [No author given.]
    • Clinical OMICs. 2019 Mar 19.

    Related:

    Original research:

    False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.

    • Genetic testing and insurance in Australia.
    • Otlowski M, Barlow-Stewart K, Lacaze P, Tiller J.
    • Aust J Gen Pract. 2019 Mar;48(3):96-99.
    • International Divergence in Gene Patenting.
    • Nicol D, Dreyfuss RC, Richard Gold E, Li W, Liddicoat J, Van Overwalle G.
    • Annu Rev Genomics Hum Genet. 2019 Feb 20. doi: 10.1146/annurev-genom-083118-015112. [Epub ahead of print]
    • Review
    • G2 Chromosomal Radiosensitivity Assay for Testing Individual Radiation Sensitivity.
    • Haskins JS, Kato TA.
    • Methods Mol Biol. 2019;1984:39-45. doi: 10.1007/978-1-4939-9432-8_5.
    • Book, Review
    • Association Between Impairment of DNA Double Strand Break Repair and Decreased Ovarian Reserve in Patients With Endometriosis.
    • Choi YS, Park JH, Lee JH, Yoon JK, Yun BH, Park JH, Seo SK, Sung HJ, Kim HS, Cho S, Lee BS.
    • Front Endocrinol (Lausanne). 2018 Dec 21;9:772. doi: 10.3389/fendo.2018.00772. eCollection 2018.
    • Differences in the Neanderthal BRCA2 gene might be related to their distinctive cognitive profile.
    • Benítez-Burraco A.
    • Hereditas. 2018 Dec 13;155:38. doi: 10.1186/s41065-018-0076-2. eCollection 2018.

    Related:

    Original Research:

    Unique divergence of the breast cancer 2 (BRCA2) gene in Neanderthals.

    • Big Data Sharing: A Crucial Democratic Issue for Genomic Medicine.
    • Derbez B.
    • Front Public Health. 2018 Nov 28;6:334. doi: 10.3389/fpubh.2018.00334. eCollection 2018.
    • Unique divergence of the breast cancer 2 (BRCA2) gene in Neanderthals.
    • Michalak P, Kang L.
    • Hereditas. 2018 Nov 3;155:34. doi: 10.1186/s41065-018-0073-5. eCollection 2018.

    Related:

    Letter:

    Differences in the Neanderthal BRCA2 gene might be related to their distinctive cognitive profile.

    • Cancer prevention and screening in a BRCA2-positive male to female transgender patient.
    • Li JZ, Tu HYV, Avram R, Pinthus J, Bordeleau L, Hodgson N.
    • Breast J. 2018 Nov;24(6):1112-1113. doi: 10.1111/tbj.13096. Epub 2018 Jul 23.
    • Commentary
    • Cancer genetics program: Follow-up on clinical genetics and genomic medicine in Qatar.
    • Al-Bader SB, Alsulaiman R, Bugrein H, Ben Omran T, Abbaszadeh F, Bakheet N, Apsa Kusasi S, Abdou N, Solomon BD, Ghazouani H.
    • Mol Genet Genomic Med. 2018 Nov;6(6):865-872. doi: 10.1002/mgg3.534. Epub 2018 Dec 16.
    • Breast cancer in transgender patients: A systematic review. Part 1: Male to female.
    • Hartley RL, Stone JP, Temple-Oberle C.
    • Eur J Surg Oncol. 2018 Oct;44(10):1455-1462. doi: 10.1016/j.ejso.2018.06.035. Epub 2018 Jul 25.
    • Review
    • Our CEO Interviews Author of “Mom’s Genes”, for Kids.
    • [No author given]
    • My Gene Counsel. 2018 Sep 26.
    • Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
    • Buckley AR, Ideker T, Carter H, Harismendy O, Schork NJ.
    • Genome Med. 2018 Sep 14;10(1):69. doi: 10.1186/s13073-018-0579-5.
    • How are genetic test results being used by Australian life insurers?
    • Barlow-Stewart K, Liepins M, Doble A, Otlowski M.
    • Eur J Hum Genet. 2018 Sep;26(9):1248-1256. doi: 10.1038/s41431-018-0198-z. Epub 2018 Jun 11.
    • Proposed outcomes measures for state public health genomic programs.
    • Doyle DL, Clyne M, Rodriguez JL, Cragun DL, Senier L, Hurst G, Chan K, Chambers DA.
    • Genet Med. 2018 Sep;20(9):995-1003. doi: 10.1038/gim.2017.229. Epub 2018 Jan 4.

    Related:

    Original research:

    Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.

    • Establishment of the Alabama Hereditary Cancer Cohort - strategies for the inclusion of underrepresented populations in cancer genetics research.
    • Bishop MR, Shah A, Shively M, Huskey ALW, Omeler SM, Bilgili EP, Jackson E, Daniell K, Stallworth E, Spina S, Shepp K, Bergstresser S, Davis A, Dean H, Gibson J, Johnson B, Merner ND.
    • Mol Genet Genomic Med. 2018 Sep;6(5):766-778. doi: 10.1002/mgg3.443. Epub 2018 Jul 1.
    • Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives.
    • Nilsson MP, Emmertz M, Kristoffersson U, Borg Å, Larsson C, Rehn M, Winter C, Saal LH, Brandberg Y, Loman N.
    • J Community Genet. 2018 Jul;9(3):201-208. doi: 10.1007/s12687-017-0341-5. Epub 2017 Oct 30.
    • Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments.
    • Petelin L, Liew D, Mitchell G, James PA, Trainer AH.
    • Value Health. 2018 Jul;21(7):891-893. doi: 10.1016/j.jval.2018.02.009. Epub 2018 May 16.
    • Letter

    Related:

    A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.

    Letter:

    A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer-Reply to letter to the editor by Petelin et al.

    • Evaluation of some direct-to-consumer genetic testing reveals inaccuracies and misinterpretations.
    • [No author given]
    • FORCE. XRAYS. 2018 Jun 28.

    Related:

    False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.

    • 5-year BRCA SCOTUS Anniversary.
    • [No author given]
    • My Gene Counsel. 2018 Jun 13.
    • Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
    • Møller P, Hovig E.
    • Med Health Care Philos. 2018 Jun;21(2):239-242. doi: 10.1007/s11019-017-9803-0.

    Related:

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    Commentary, Reply:

    Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health medicine.

    • Role of BRCA1 in Neuronal Death in Alzheimer's Disease.
    • Wezyk M, Zekanowski C.
    • ACS Chem Neurosci. 2018 May 16;9(5):870-872. doi: 10.1021/acschemneuro.8b00149. Epub 2018 Apr 10.
    • Childbearing after breast cancer among young survivors.
    • [No author given]
    • FORCE. XRAYS. 2018 May 10.

    Related:

    Live birth outcomes after adolescent and young adult breast cancer.

    • BRCA1 and BRCA2 tumor suppressors in neural crest cells are essential for craniofacial bone development.
    • Kitami K, Kitami M, Kaku M, Wang B, Komatsu Y.
    • PLoS Genet. 2018 May 2;14(5):e1007340. doi: 10.1371/journal.pgen.1007340. eCollection 2018 May.
    • Challenges in recruiting African-American women for a breast cancer genetics study.
    • Compadre AJ, Simonson ME, Gray K, Runnells G, Kadlubar S, Zorn KK.
    • Hered Cancer Clin Pract. 2018 Apr 24;16:8. doi: 10.1186/s13053-018-0091-3. eCollection 2018.
    • Brca1 Is Upregulated by 5-Aza-CdR and Promotes DNA Repair and Cell Survival, and Inhibits Neurite Outgrowth in Rat Retinal Neurons.
    • Wang Q, Xu L, Chen P, Xu Z, Qiu J, Ge J, Yu K, Zhuang J.
    • Int J Mol Sci. 2018 Apr 17;19(4). pii: E1214. doi: 10.3390/ijms19041214.
    • Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014.
    • Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ.
    • Genet Med. 2018 Apr;20(4):428-434. doi: 10.1038/gim.2017.118. Epub 2017 Sep 21.
    • Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
    • Arai M, Yokoyama S, Watanabe C, Yoshida R, Kita M, Okawa M, Sakurai A, Sekine M, Yotsumoto J, Nomura H, Akama Y, Inuzuka M, Nomizu T, Enomoto T, Nakamura S.
    • J Hum Genet. 2018 Apr;63(4):447-457. doi: 10.1038/s10038-017-0355-1. Epub 2017 Nov 8.
    • False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.
    • Tandy-Connor S, Guiltinan J, Krempely K, LaDuca H, Reineke P, Gutierrez S, Gray P, Tippin Davis B.
    • Genet Med. 2018 Mar 22. doi: 10.1038/gim.2018.38. [Epub ahead of print]

    Related:

    Commentary:

    Attention: Direct-To-Consumer patrons: Proceed with caution.

    Research news: Evaluation of some direct-to-consumer genetic testing reveals inaccuracies and misinterpretations (FORCE. XRAYS.)

    Press: Wrangle Over DTC Results—Ambry Study Highlights 40% False Positives, 23andMe Defends Tests, and Experts Weigh In. (Clinical OMICs)

    Press: Ambry and My Gene Counsel Team Up on Tests to Confirm DTC Results, Counseling. (Clinical OMICs)

    • The Right Not to Know: When Ignorance Is Bliss but Deadly.
    • Clausen AM.
    • Global Health NOW. 2018 Mar 20.

    Related:

    Commentary: The right not to know when not knowing is dangerous. (FORCE. XRAYS.)

    • BRCA1 gene: function and deficiency.
    • Takaoka M, Miki Y.
    • Int J Clin Oncol. 2018 Feb;23(1):36-44. doi: 10.1007/s10147-017-1182-2. Epub 2017 Sep 7.
    • Review
    • Contralateral breast cancers: Independent cancers or metastases?
    • Begg CB, Ostrovnaya I, Geyer FC, Papanastasiou AD, Ng CKY, Sakr RA, Bernstein JL, Burke KA, King TA, Piscuoglio S, Mauguen A, Orlow I, Weigelt B, Seshan VE, Morrow M, Reis-Filho JS.
    • Int J Cancer. 2018 Jan 15;142(2):347-356. doi: 10.1002/ijc.31051. Epub 2017 Sep 28.
    • Breast Cancer Disparities: How Can We Leverage Genomics to Improve Outcomes?
    • Davis MB, Newman LA.
    • Surg Oncol Clin N Am. 2018 Jan;27(1):217-234. doi: 10.1016/j.soc.2017.07.009.
    • Review
    • Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.
    • Wezyk M, Szybinska A, Wojsiat J, Szczerba M, Day K, Ronnholm H, Kele M, Berdynski M, Peplonska B, Fichna JP, Ilkowski J, Styczynska M, Barczak A, Zboch M, Filipek-Gliszczynska A, Bojakowski K, Skrzypczak M, Ginalski K, Kabza M, Makalowska I, Barcikowska-Kotowicz M, Wojda U, Falk A, Zekanowski C.
    • J Alzheimers Dis. 2018;62(1):175-202. doi: 10.3233/JAD-170830.
    • The Rise and Fall and Rise of Linkage Analysis as a Technique for Finding and Characterizing Inherited Influences on Disease Expression.
    • Lipner EM, Greenberg DA.
    • Methods Mol Biol. 2018;1706:381-397. doi: 10.1007/978-1-4939-7471-9_21.
    • Review
    • International Szent-Györgyi Prize for Progress in Cancer Research: basic and translational research recognition : Mary-Claire King received the 2016 Prize for her pioneering research that demonstrated the first evidence of genetic predisposition to breast cancer.
    • Hartmann H, Zhao J, Ba S.
    • Chin J Cancer. 2017 Nov 21;36(1):92. doi: 10.1186/s40880-017-0258-8.
    • Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer.
    • D'Aloisio AA, Nichols HB, Hodgson ME, Deming-Halverson SL, Sandler DP.
    • BMC Cancer. 2017 Oct 23;17(1):692. doi: 10.1186/s12885-017-3686-6.
    • To Have Or Not To Have Genetic Testing?
    • [No author given]
    • My Gene Counsel. 2017 Oct 17.
    • Hereditary gynaecologic cancers in Nepal: a proposed model of care to serve high risk populations in developing countries.
    • Pokharel HP, Hacker NF, Andrews L.
    • Hered Cancer Clin Pract. 2017 Sep 18;15:12. doi: 10.1186/s13053-017-0072-y. eCollection 2017.
    • The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2.
    • Pfeffer CM, Ho BN, Singh ATK.
    • Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):293-298.
    • Breast Cancer Genetic Testing Among African Patients With Breast Cancer: Deoxyribonucleic Acid Extraction From Tumor Tissue and International Multidisciplinary Partnerships.
    • Amankwaa-Frempong E, Yeboah FA, Nguah SB, Newman LA.
    • JAMA Surg. 2017 Aug 1;152(8):800-801. doi: 10.1001/jamasurg.2017.1090.
    • Development of a Streamlined Work Flow for Handling Patients’ Genetic Testing Insurance Authorizations.
    • Uhlmann WR, Schwalm K, Raymond VM
    • J Genet Couns. 2017 Aug;26(4):657-668. doi: 10.1007/s10897-017-0098-3. Epub 2017 Apr 24.
    • Outcomes of retesting BRCA negative patients using multigene panels.
    • Yadav S, Reeves A, Campian S, Paine A, Zakalik D.
    • Fam Cancer. 2017 Jul;16(3):319-328. doi: 10.1007/s10689-016-9956-7.
    • Genetic testing and counseling of a recipient after bone marrow transplant from a sibling harboring a germline BRCA1 pathogenic mutation.
    • Škerl P, Krajc M, Blatnik A, Novaković S.
    • Oncol Rep. 2017 Jul;38(1):279-282. doi: 10.3892/or.2017.5703. Epub 2017 Jun 6.
    • Case report
    • BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.
    • Deihimi S, Lev A, Slifker M, Shagisultanova E, Xu Q, Jung K, Vijayvergia N, Ross EA, Xiu J, Swensen J, Gatalica Z, Andrake M, Dunbrack RL, El-Deiry WS.
    • Oncotarget. 2017 Jun 20;8(25):39945-39962. doi: 10.18632/oncotarget.18098.

    Related:

    News:

    New perspectives for colorectal cancer.

    • Clinical Cancer Genetics Disparities among Latinos.
    • Cruz-Correa M, Pérez-Mayoral J, Dutil J, Echenique M, Mosquera R, Rivera-Román K, Umpierre S, Rodriguez-Quilichini S, Gonzalez-Pons M, Olivera MI, Pardo S; Puerto Rico Clinical Cancer Genetics Consortia.
    • J Genet Couns. 2017 Jun;26(3):379-386. doi: 10.1007/s10897-016-0051-x. Epub 2016 Dec 12.
    • Review
    • Germline gene polymorphisms predisposing domestic mammals to carcinogenesis.
    • Flisikowski K, Flisikowska T, Sikorska A, Perkowska A, Kind A, Schnieke A, Switonski M.
    • Vet Comp Oncol. 2017 Jun;15(2):289-298. doi: 10.1111/vco.12186. Epub 2015 Nov 17.
    • A mass spectrometry-based multiplex SNP genotyping by utilizing allele-specific ligation and strand displacement amplification.
    • Park JH, Jang H, Jung YK, Jung YL, Shin I, Cho DY, Park HG.
    • Biosens Bioelectron. 2017 May 15;91:122-127. doi: 10.1016/j.bios.2016.10.065. Epub 2016 Nov 24.
    • Incorporation of the time aspect into the liability-threshold model for case-control-family data.
    • Cederkvist L, Holst KK, Andersen KK, Glidden DV, Frederiksen K, Kjaer SK, Scheike TH.
    • Stat Med. 2017 May 10;36(10):1599-1618. doi: 10.1002/sim.7229. Epub 2017 Jan 23.
    • Study of Selected BRCA1, BRCA2, and PIK3CA Mutations in Benign and Malignant Lesions of Anogenital Mammary-Like Glands.
    • Konstantinova AM, Shelekhova KV, Imyanitov EN, Iyevleva A, Kacerovska D, Michal M, Kazakov DV.
    • Am J Dermatopathol. 2017 May;39(5):358-362. doi: 10.1097/DAD.0000000000000725.
    • Overexpression of BRCA1 in Neural Stem Cells Enhances Cell Survival and Functional Recovery after Transplantation into Experimental Ischemic Stroke.
    • Xu P, Shi X, Zhang X, Liu Q, Xie Y, Hong Y, Li J, Peng M, Liu X, Xu G.
    • Oxid Med Cell Longev. 2019 Apr 3;2019:8739730. doi: 10.1155/2019/8739730. eCollection 2019.
    • BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer.
    • Jamard E, Volard B, Dugué AE, Legros A, Leconte A, Clarisse B, Davy G, Polycarpe F, Dugast C, Abadie C, Frebourg T, Tinat J, Tennevet I, Layet V, Joly F, Castéra L, Berthet P, Vaur D, Krieger S.
    • Fam Cancer. 2017 Apr;16(2):167-171. doi: 10.1007/s10689-016-9940-2.
    • Breast Health Services: Accuracy of Benefit Coverage Information in the Individual Insurance Marketplace.
    • Hamid MS, Kolenic GE, Dozier J, Dalton VK, Carlos RC.
    • J Am Coll Radiol. 2017 Apr;14(4):482-487.e5. doi: 10.1016/j.jacr.2016.12.002. Epub 2017 Feb 3.
    • Genetic Cancer Risk Assessment for Breast Cancer in Latin America.
    • Chavarri-Guerra Y, Blazer KR, Weitzel JN.
    • Rev Invest Clin. 2017 Mar-Apr;69(2):94-102.
    • [Analysis of DNA Methylation in BRCA2 Gene Using Electrode Biochips].
    • Bartošík M, Bartáková D.
    • Klin Onkol. 2017 Spring;30(Supplementum1):149-152.
    • Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
    • Solbrække KN, Søiland H, Lode K, Gripsrud BH.
    • Med Health Care Philos. 2017 Mar;20(1):89-103. doi: 10.1007/s11019-016-9737-y.

    Related:

    Commentary:

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    Commentary, Reply:

    Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health medicine.

    • Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.
    • Kobayashi Y, Yang S, Nykamp K, Garcia J, Lincoln SE, Topper SE.
    • Genome Med. 2017 Feb 6;9(1):13. doi: 10.1186/s13073-017-0403-7.
    • Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies.
    • Rizzolo P, Silvestri V, Ottini L.
    • Breast Cancer Res Treat. 2017 Feb;162(1):199-200. doi: 10.1007/s10549-017-4108-9. Epub 2017 Jan 16.
    • Letter
    • Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
    • Moran O, Nikitina D, Royer R, Poll A, Metcalfe K, Narod SA, Akbari MR, Kotsopoulos J.
    • Breast Cancer Res Treat. 2017 Jan;161(1):135-142. doi: 10.1007/s10549-016-4038-y. Epub 2016 Oct 31.
    • BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.
    • Chun DS, Berse B, Venne VL, DuVall SL, Filipski KK, Kelley MJ, Meyer LJ, Icardi MS, Lynch JA.
    • Fam Cancer. 2017 Jan;16(1):41-49. doi: 10.1007/s10689-016-9921-5.
    • Impact of Payer Constraints on Access to Genetic Testing.
    • Whitworth P, Beitsch P, Arnell C, Cox HC, Brown K, Kidd J, Lancaster JM.
    • J Oncol Pract. 2017 Jan;13(1):e47-e56. doi: 10.1200/JOP.2016.013581. Epub 2016 Oct 23.
    • A Lens for Evaluating Genetic Information Governance Models: Balancing Equity, Efficiency and Sustainability.
    • Skorve E, Vassilakopoulou P, Aanestad M, Grünfeld T.
    • Stud Health Technol Inform. 2017;235:298-302.
    • Genetic testing in a gynaecological oncology care in developing countries-knowledge, attitudes and perception of Nepalese clinicians.
    • Pokharel HP, Hacker NF, Andrews L.
    • Gynecol Oncol Res Pract. 2016 Dec 5;3:12. eCollection 2016.
    • Genetic Testing After Previous BRCA Testing: A Case Study.
    • Ward M.
    • Clin J Oncol Nurs. 2016 Dec 1;20(6):660-663.
    • Case report
    • Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
    • Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B.
    • Clin Epigenetics. 2016 Nov 14;8:115. eCollection 2016.
    • Impact of Payer Constraints on Access to Genetic Testing.
    • Whitworth P, Beitsch P, Arnell C, Cox HC, Brown K, Kidd J, Lancaster JM
    • J Oncol Pract. 2016 Oct 23. doi: 10.1200/JOP.2016.013581.

    Related:

    News: Payers’ Genetic Counselor Mandates Decrease Access to BRCA 1/2 Testing (Clinical Omics)

    • Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer.
    • Mary Chris Jaklevic
    • Health News Review. 2016 Oct 13.

    Related:

    Comments from NSGC Discussion Forum Cancer SIG

    Subject: Conflict of Interest and BRCA

    • How Patients Can Share Their Data.
    • [No author given]
    • My Gene Counsel. 2016 Oct 7.
    • Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors.
    • Jones T, Lockhart JS, Mendelsohn-Victor KE, Duquette D, Northouse LL, Duffy SA, Donley R, Merajver SD, Milliron KJ, Roberts JS, Katapodi MC.
    • Am J Prev Med. 2016 Oct;51(4):427-36. doi: 10.1016/j.amepre.2016.03.016. Epub 2016 Apr 23.
    • Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.
    • Hamilton JG, Mays D, DeMarco T, Tercyak KP.
    • Fam Cancer. 2016 Oct;15(4):513-22. doi: 10.1007/s10689-016-9876-6.
    • Angelina and Brad effect.
    • Eisinger F.
    • Fam Cancer. 2016 Oct;15(4):541-2. doi: 10.1007/s10689-016-9908-2.
    • Letter
    • Hereditary breast and gynecological tumors: italian legal issues.
    • DI Vella G.
    • Minerva Ginecol. 2016 Oct;68(5):613-9. Epub 2016 Feb 29.
    • Translating genetics beyond bench and bedside: A comparative perspective on health care infrastructures for 'familial' breast cancer.
    • Aarden E.
    • Appl Transl Genom. 2016 Sep 29;11:48-54. doi: 10.1016/j.atg.2016.09.001. eCollection 2016.
    • HIPAA complaint alleges myriad genetics withheld variant data from patients: Allegation highlights the importance of data sharing, new HIPAA guidance.
    • [No authors listed]
    • Am J Med Genet A. 2016 Sep;170(9):2234-5. doi: 10.1002/ajmg.a.37886.
    • Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-grade Serous Carcinoma: A Review of the Evidence.
    • Sherman M, Drapkin R, Horowitz NS, Crum CP, Friedman S, Kwon J, Levine DA, Shih IM, Shoupe D, Swisher EM, Walker J, Trabert B, Greene MH, Samimi G, Temkin SM, Minasian L.
    • Cancer Prev Res (Phila). 2016 Sep;9(9):713-20. doi: 10.1158/1940-6207.CAPR-15-0384. Epub 2016 May 24.
    • Review
    • A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.
    • Yerushalmi R, Rizel S, Zoref D, Sharon E, Eitan R, Sabah G, Grubstein A, Rafson Y, Cohen M, Magen A, Birenboim I, Margel D, Ozlavo R, Sulkes A, Brenner B, Perry S.
    • Isr Med Assoc J. 2016 Sep;18(9):549-552.

    Related:

    Editorial:

    Handling Individuals with High Cancer Risk: One Size Doesn't Fit All.

    • Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
    • McCarthy AM, Bristol M, Domchek SM, Groeneveld PW, Kim Y, Motanya UN, Shea JA, Armstrong K.
    • J Clin Oncol. 2016 Aug 1;34(22):2610-8. doi: 10.1200/JCO.2015.66.0019. Epub 2016 May 9.

    Related:

    Research News: Racial disparities in BRCA testing: Why? (FORCE)

    • Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples.
    • Fackenthal JD, Yoshimatsu T, Zhang B, de Garibay GR, Colombo M, De Vecchi G, Ayoub SC, Lal K, Olopade OI, Vega A, Santamariña M, Blanco A, Wappenschmidt B, Becker A, Houdayer C, Walker LC, López-Perolio I, Thomassen M, Parsons M, Whiley P, Blok MJ, Brandão RD, Tserpelis D, Baralle D, Montalban G, Gutiérrez-Enríquez S, Díez O, Lazaro C; kConFaB Investigators, Spurdle AB, Radice P, de la Hoya M.
    • J Med Genet. 2016 Aug;53(8):548-558. doi: 10.1136/jmedgenet-2015-103570. Epub 2016 Apr 8.

    Related:

    Press: Naturally Occurring BRCA2 Alternative mRNA Splicing Events in Clinically Relevant Samples. (Medscape Oncology)

    • Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis.
    • Castro M, Vierkoetter K, Prager D, Montgomery S, Sedgwick K.
    • Case Rep Oncol. 2016 Jul 21;9(2):387-394.
    • Cambridge start-up expands its genetic test offering.
    • Rebecca Burbidge.
    • PHG Foundation. 2016 July 15.
    • Methods to identify BRCA testing in claims data.
    • Lynch J, Berse B.
    • Am J Obstet Gynecol. 2016 Jul;215(1):133-4. doi: 10.1016/j.ajog.2016.03.049. Epub 2016 Apr 12.

    Related:

    Letter / Reply:

    Reply.

    • Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.
    • Hein A, Gass P, Walter CB, Taran FA, Hartkopf A, Overkamp F, Kolberg HC, Hadji P, Tesch H, Ettl J, Wuerstlein R, Lounsbury D, Lux MP, Lüftner D, Wallwiener M, Müller V, Belleville E, Janni W, Fehm TN, Wallwiener D, Ganslandt T, Ruebner M, Beckmann MW, Schneeweiss A, Fasching PA, Brucker SY.
    • Breast Cancer Res Treat. 2016 Jul;158(1):59-65. doi: 10.1007/s10549-016-3850-8. Epub 2016 Jun 9.
    • Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
    • Komenaka IK, Nodora JN, Madlensky L, Winton LM, Heberer MA, Schwab RB, Weitzel JN, Martinez ME.
    • J Community Genet. 2016 Jul;7(3):177-83. doi: 10.1007/s12687-015-0257-x. Epub 2015 Dec 21.
    • A cost analysis of a cancer genetic service model in the UK.
    • Slade I, Hanson H, George A, Kohut K, Strydom A, Wordsworth S, Rahman N; MCG programme.
    • J Community Genet. 2016 Jul;7(3):185-94. doi: 10.1007/s12687-016-0266-4. Epub 2016 Feb 27.
    • Exclusive: Breast cancer gene database gives clearer picture of risk.
    • Susan Miller.
    • USA Today. 2016 Jun 1.
    • Myriad Genetics embroiled in breast-cancer data fight - again.
    • Check Hayden E.
    • Nature. 2016 May 20;533(7604):449. doi: 10.1038/nature.2016.19953.
    • Patients challenge Myriad Genetics for access to their gene data.
    • Leah Samuel.
    • STAT. Health. 2016 May 19.
    • Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients.
    • Hamam D, Abdouh M, Gao ZH, Arena V, Arena M, Arena GO.
    • J Exp Clin Cancer Res. 2016 May 14;35(1):80. doi: 10.1186/s13046-016-0360-9.
    • Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.
    • Palmero EI, Galvão HC, Fernandes GC, Paula AE, Oliveira JC, Souza CP, Andrade CE, Romagnolo LG, Volc S, C Neto M, Sabato C, Grasel R, Mauad E, Reis RM, Michelli RA.
    • Genet Mol Biol. 2016 May 13;39(2):168-177. doi: 10.1590/1678-4685-GMB-2014-0364.
    • Addressing inherited predisposition for breast cancer in transplant recipients.
    • Yang RL, Kurian AW, Winton LM, Weill D, Patel K, Kingham K, Wapnir IL.
    • J Surg Oncol. 2016 May;113(6):605-8. doi: 10.1002/jso.24193. Epub 2016 Feb 10.
    • Case report, Review
    • More People Seek Genetic Testing, But There Aren't Enough Counselors.
    • Todd Bookman.
    • NPR. Morning Edition. 2016 Apr 18.
    • High use of complementary and alternative medicine among a large cohort of women with a family history of breast cancer: the Sister Study.
    • Greenlee H, Sardo Molmenti CL, Falci L, Ulmer R, Deming-Halverson S, DeRoo LA, Sandler DP.
    • Breast Cancer Res Treat. 2016 Apr;156(3):527-38. doi: 10.1007/s10549-016-3740-0. Epub 2016 Mar 26.
    • Relationship between Caffeine and Levels of DNA Repair and Oxidative Stress in Women with and without a BRCA1 Mutation.
    • Nikitina D, Chen Z, Vallis K, Poll A, Ainsworth P, Narod SA, Kotsopoulos J.
    • J Nutrigenet Nutrigenomics. 2015 [2016 Apr;]8(4-6):174-84. doi: 10.1159/000439110. Epub 2015 Dec 16.
    • Breast cancer 1 (BRCA1)-deficient embryos develop normally but are more susceptible to ethanol-initiated DNA damage and embryopathies.
    • Shapiro AM, Miller-Pinsler L, Wells PG.
    • Redox Biol. 2016 Apr;7:30-8. doi: 10.1016/j.redox.2015.11.005. Epub 2015 Nov 18.
    • Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model.
    • Chapa J, An G, Kulkarni SA.
    • PLoS One. 2016 Mar 29;11(3):e0152298. doi: 10.1371/journal.pone.0152298. eCollection 2016.
    • Genetic Test Firm to Make Customers’ Data Publicly Available.
    • Andrew Pollack.
    • New York Times. Business Day. 2016 Mar 8.
    • Clinical and Pathological Characteristics of Incidental Diagnostic Early Occult Malignancy After Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers.
    • Lavie O, Moskoviz MG, Auslender R, Gemer O, Bitterman A, Younes G, Segev Y.
    • Int J Gynecol Cancer. 2016 Feb;26(2):233-9. doi: 10.1097/IGC.0000000000000624.
    • Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
    • Modell SM, Greendale K, Citrin T, Kardia SL.
    • Healthcare (Basel). 2016 Jan 27;4(1). pii: E14. doi: 10.3390/healthcare4010014.
    • Sweeping Up after the Kardashians: What We Wish had been Covered in Their Genetic Testing Episode.
    • [No author given]
    • My Gene Counsel. 2016 Jan 22.
    • Gene-environment interaction and risk of breast cancer.
    • Rudolph A, Chang-Claude J, Schmidt MK.
    • Br J Cancer. 2016 Jan 19;114(2):125-133. doi: 10.1038/bjc.2015.439. Epub 2016 Jan 12.
    • Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric Patient.
    • Bhatla T, Dandekar S, Lu BY, Wang J, Han E, Bitterman D, Jones CL, Evensen NA, Magid M, Meyer JA, Carroll WL.
    • J Pediatr Hematol Oncol. 2016 Jan;38(1):e21-5. doi: 10.1097/MPH.0000000000000463.
    • Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA Consortium.
    • Nakamura S, Kwong A, Kim SW, Iau P, Patmasiriwat P, Dofitas R, Aryandono T, Hu Z, Huang CS, Ginsburg O, Rashid MU, Sarin R, Teo SH.
    • Public Health Genomics. [2016 Jan;]19(1):53-60. doi: 10.1159/000441714. Epub 2015 Nov 18.
    • DAKOTACARE Update: Genetic Counseling Requirement for BRCA 1/2 Testing.
    • Amundson EP, Jamison S.
    • S D Med. 2016 Jan;69(1):36.
    • Letter
    • Legislation regulating availability of breast cancer treatment with particular focus on prophylactic mastectomy.
    • Rolska P, Łapa J.
    • Folia Med Cracov. 2016;56(2):73-94.
    • Some Legal Issues Regarding the Patenting of Human Genetic Materials.
    • MacFarlane P, Kontoleon B.
    • J Law Med. 2016;24(1):181-202.
    • Some Legal Issues Regarding the Patenting of Human Genetic Materials.
    • MacFarlane P, Kontoleon B.
    • J Law Med. 2016;24(1):181-202.
    • The Science -- Or Lack Of It -- Behind Genetic Tests Offered In The Workplace.
    • David Shaywitz.
    • Forbes. 2015 Dec 18.
    • ACOG Objects to Insurers' Genetic Counseling Requirements for BRCA Testing.
    • [No author given]
    • GenomeWeb. 2015 Dec 18.
    • The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment.
    • Basse C, Arock M.
    • Int J Cancer. 2015 Dec 15;137(12):2785-94. doi: 10.1002/ijc.29347. Epub 2014 Dec 1.
    • Review
    • Genetic Testing May Be Coming to Your Office.
    • Rachel Emma Silverman.
    • The Wall Street Journal. Business. 2015 Dec 15.
    • Beyond BRCA: Testing negative and living in the 'gray zone' for cancer risk.
    • [No author given]
    • My Gene Counsel. 2015 Dec 1.
    • Passage of Medicare mandate fails to shorten time to BRCA testing in ovarian cancer patients.
    • Olga T. Filippova, Paul J. Feustel, Lisa M. Armao, Joyce N. Barlin, Timothy J. McElrath, Patrick F. Timmins, Daniel C. Kredentser, Heidi E. Godoy.
    • Gynecologic Oncology. 2015 Dec;139(3):594. 2015 NEAGO ABSTRACTS. doi: 10.1016/j.ygyno.2015.09.053.
    • Conference abstract
    • "Maybe they have found something new" participants' views on returning cohort psychosocial survey results.
    • Bureau E, Pellegrini I, Noguès C, Lasset C, Julian-Reynier C.
    • Health Expect. 2015 Dec;18(6):2425-36. doi: 10.1111/hex.12211. Epub 2014 May 30.
    • Risk factors and biomarkers of life-threatening cancers.
    • Autier P.
    • Ecancermedicalscience. 2015 Nov 24;9:596. doi: 10.3332/ecancer.2015.596. eCollection 2015.
    • Hereditary Cancer, Insurance, and Your Legal Rights.
    • Anya Prince.
    • FORCE. Be Empowered Webinars. 2015 Nov 18.
    • Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility.
    • Piccolo SR, Andrulis IL, Cohen AL, Conner T, Moos PJ, Spira AE, Buys SS, Johnson WE, Bild AH.
    • BMC Med Genomics. 2015 Nov 4;8(1):72. doi: 10.1186/s12920-015-0145-6.
    • Discussion: The Next Big Things in the BRCA World.
    • [No author given].
    • My Gene Counsel. 2015 Nov 4.
    • Molding BRCA2 function through its interacting partners.
    • Martinez JS, Baldeyron C, Carreira A.
    • Cell Cycle. 2015 Nov 2;14(21):3389-95. doi: 10.1080/15384101.2015.1093702.
    • Review
    • Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients.
    • Loibl S, Schmidt A, Gentilini O, Kaufman B, Kuhl C, Denkert C, von Minckwitz G, Parokonnaya A, Stensheim H, Thomssen C, van Calsteren K, Poortmans P, Berveiller P, Markert UR, Amant F.
    • JAMA Oncol. 2015 Nov 1;1(8):1145-1153. doi: 10.1001/jamaoncol.2015.2413.
    • Review
    • Functional assessment of intrinsic disorder central domains of BRCA1.
    • Yadav LR, Rai S, Hosur MV, Varma .
    • J Biomol Struct Dyn. 2015 Nov;33(11):2469-78. doi: 10.1080/07391102.2014.1000973. Epub 2015 Jan 23.
    • The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
    • Trivers KF, Rodriguez JL, Cox SL, Crane BE, Duquette D.
    • Healthcare (Basel). 2015 Oct 15;3(4):948-63. doi: 10.3390/healthcare3040948.
    • Color Genomics Launches Benefits Program for Breast, Ovarian Cancer Risk Testing.
    • [No author given]
    • Clinical OMICs. 2015 Sep 30.
    • Availability and payer coverage of BRCA1/2 tests and gene panels.
    • Clain E, Trosman JR, Douglas MP, Weldon CB, Phillips KA.
    • Nat Biotechnol. 2015 Sep 8;33(9):900-2. doi: 10.1038/nbt.3322.
    • Letter
    • Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.
    • Alkner S, Tang MH, Brueffer C, Dahlgren M, Chen Y, Olsson E, Winter C, Baker S, Ehinger A, Rydén L, Saal LH, Fernö M, Gruvberger-Saal SK.
    • Breast Cancer Res. 2015 Aug 5;17(1):102. doi: 10.1186/s13058-015-0608-x.
    • Caution: Falling Price Zone.
    • Alex Philippidis.
    • Clinical OMICs. 2(7):26-8. 2015 Ju
    • BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.
    • Kwiatkowski F, Arbre M, Bidet Y, Laquet C, Uhrhammer N, Bignon YJ.
    • PLoS One. 2015 Jun 5;10(6):e0127363. doi: 10.1371/journal.pone.0127363. eCollection 2015.
    • Breast cancer: Diagnostic service shares BRCA data.
    • Strom C.
    • Nature. 2015 Jun 4;522(7554):34. doi: 10.1038/522034e.
    • Comment, Lettere

    Related:

    Editorial

    Thank you for sharing.

    • Curating the Way to Better Determinants of Genetic Risk.
    • Phimister EG.
    • N Engl J Med. 2015 Jun 4;372(23):2227-2228. Epub 2015 May 27.
    • Editorial / Commentary
    • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk.
    • Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD.
    • N Engl J Med. 2015 Jun 4;372(23):2243-2257. Epub 2015 May 27.

    Related:

    Comments on NSGC Discussion Forum Cancer SIG

    Subject: Excellent review paper in NEJM

    Comment / Letter

    ClinGen and Genetic Testing.

    • Breast cancer in women in their thirties (2007-2013): A retrospective review.
    • Arleo EK, Reichman M, Dashevsky BZ, Babagbemi K, Drotman M.
    • Breast Dis. 2015 Jun 1;35(2):87-93. doi: 10.3233/BD-150400.
    • Impact of BRCA1/2 mutation on young women's 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort).
    • Mancini J, Mouret-Fourme E, Noguès C, Julian-Reynier C.
    • Fam Cancer. 2015 Jun;14(2):273-9. doi: 10.1007/s10689-014-9777-5.
    • CMS Unveils Draft LCD for BRCA1 and BRCA2 Genetic Tests.
    • [No author given]
    • Clinical OMICs. 2015 May 18.
    • CMS Unveils Draft LCD for BRCA1 and BRCA2 Genetic Tests.
    • [No author given]
    • GEN: Genetic Engineering and Biotechnology News. 2015 May 18.
    • I Love Them, I Love Them Not….. Proposed Revised Medicare Guidelines For Coverage of BRCA Testing.
    • Robert Resta.
    • The DNA Exchange. 2015 May 17.
    • Mary-Claire King on Inherited Breast/Ovarian Cancer.
    • Dan Koboldt.
    • MassGenomics. 2015 May 14.
    • Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
    • Cragun D, Bonner D, Kim J, Akbari MR, Narod SA, Gomez-Fuego A, Garcia JD, Vadaparampil ST, Pal T.
    • Breast Cancer Res Treat. 2015 May;151(1):169-76. doi: 10.1007/s10549-015-3374-7. Epub 2015 Apr 14.
    • Thank you for sharing.
    • [No authors listed]
    • Nature. 2015 Apr 30;520(7549):585. doi: 10.1038/520585a.

    Related:

    Comment / Letter

    Breast cancer: Diagnostic service shares BRCA data.

    • BRCA Share (formerly UMD-BRCA1 mutations database) Home.
    • [No author given]
    • BRCA Share™ (formerly UMD-BRCA1 mutations database). 2015 Apr 21.
    • BRCA gene datashare will help detect cancer risk.
    • Susan Miller.
    • USA Today. 2015 Apr 21.
    • Breast Cancer in Young Women: Research Priorities. A Report of the Young Survival Coalition Research Think Tank Meeting.
    • Korde LA, Partridge AH, Esser M, Lewis S, Simha J, Johnson RH.
    • J Adolesc Young Adult Oncol. 2015 Mar;4(1):34-43. doi: 10.1089/jayao.2014.0049.
    • Has the BRCA Monopoly Been Reborn?
    • Ellen T. Matloff.
    • My Gene Counsel. 2015 Feb 24.
    • Low-level constitutional mosaicism of a de novoBRCA1 gene mutation.
    • Friedman E, Efrat N, Soussan-Gutman L, Dvir A, Kaplan Y, Ekstein T, Nykamp K, Powers M, Rabideau M, Sorenson J, Topper S.
    • Br J Cancer. 2015 Feb 17;112(4):765-768. doi: 10.1038/bjc.2015.14. Epub 2015 Jan 29.
    • Metastatic lobular breast carcinoma mimicking primary signet ring adenocarcinoma in a patient with a suspected CDH1 mutation.
    • Mahmud N, Ford JM, Longacre TA, Parent R, Norton JA.
    • J Clin Oncol. 2015 Feb 1;33(4):e19-21. doi: 10.1200/JCO.2013.49.1159. Epub 2014 Mar 3.
    • Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS).
    • Crook A, Plunkett L, Forrest LE, Hallowell N, Wake S, Alsop K, Gleeson M, Bowtell D, Mitchell G; Australian Ovarian Cancer Study Group, Young MA.
    • Eur J Hum Genet. 2015 Feb;23(2):152-8. doi: 10.1038/ejhg.2014.86. Epub 2014 May 14.
    • American BRCA Outcomes and Utilization of Testing (ABOUT) Study: A Pragmatic Research Model that Incorporates Personalized Medicine/Patient-Centered Outcomes in a Real World Setting.
    • Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, Virgo KS, Lynch K, Andrews JE, Aguado Loi CX, Bauer JE, Casares C, Teten RT, Kondoff MR, Molina AD, Abdollahian M, Brand L, Walker GS, Sutphen R.
    • J Genet Couns. 2015 Feb;24(1):18-28. doi: 10.1007/s10897-014-9750-3. Epub 2014 Sep 12.
    • Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: a report on the College of American Pathologists proficiency testing surveys.
    • Tafe LJ, Datto MB, Palomaki GE, Lacbawan FL.
    • Genet Med. 2015 Jan;17(1):58-62. doi: 10.1038/gim.2014.77. Epub 2014 Jun 19.
    • The curious case of a woman with two BRCA1 mutations in trans.
    • Rodney J Scott, Michelle Wong-Brown, Mary McPhillips, Susan Dooley, Allan Spigelman, Margaret Gleeson, Cliff Meldrum.
    • Hereditary Cancer in Clinical Practice 2015, 13(Suppl 2):A11; Meeting abstracts from the Annual Conference on Hereditary Cancers 2014. doi:10.1186/1897-4287-13-S2-A11
    • Conference Abstract
    • The importance to update the guidelines for the use of genetic testing in noncancer patients in Brazil.
    • Lajus TB.
    • Rev Saude Publica. 2015;49:71. doi: 10.1590/S0034-8910.2015049005988. Epub 2015 Oct 13.
    • Profile of Mary-claire king, 2014 lasker-koshland special achievement in medical science awardee.
    • Chakravarti A.
    • Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17690-2. doi: 10.1073/pnas.1418785111. Epub 2014 Nov 25.
    • The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data.
    • Raju R, Paul AM, Asokachandran V, George B, Radhamony L, Vinaykumar M, Girijadevi R, Pillai MR.
    • Breast Cancer Res. 2014 Dec 4;16(6):490. doi: 10.1186/s13058-014-0490-y.
    • THE MUTANT DIARIES: UNZIPPING MY GENES, A musical about telling cancer to take a hike.
    • Deepti Babu.
    • Perspectives in Genetic Counseling 36(4):8-9, 2014 Qtr 4.
    • PROMPT to detail breast cancer risk.
    • [No authors listed]
    • Cancer Discov. 2014 Dec;4(12):1362. doi: 10.1158/2159-8290.CD-NB2014-163. Epub 2014 Oct 31.
    • CXM: A New Tool for Mapping Breast Cancer Risk in the Tumor Microenvironment.
    • Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, Lazarova Z, Lazar J, North PE, LaViolette PS, Dwinell MB, Shull JD, Jacob HJ.
    • Cancer Res. 2014 Nov 15;74(22):6419-29. doi: 10.1158/0008-5472.CAN-13-3212. Epub 2014 Aug 29.
    • Invasive ductal carcinoma of the breast in a 14-year-old girl.
    • Kim JY, Kim YJ, Kim SH, Kang BJ, Song BJ.
    • Pediatr Radiol. 2014 Nov;44(11):1446-9. doi: 10.1007/s00247-014-3003-3. Epub 2014 Jul 6.
    • Case Report
    • Retraction: Relation between HPV genotypes and BRCA mutation in familial breast cancer.
    • Rassi H, Mohammadian T, Salmanpor S, Gholami Roudmajani E.
    • J Microbiol Biotechnol. 2014 Oct 8. doi: 10.4014/jmb.1407.07011. [Epub ahead of print]
    • Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
    • Brannon Traxler L, Martin ML, Kerber AS, Bellcross CA, Crane BE, Green V, Matthews R, Paris NM, Gabram SG.
    • Ann Surg Oncol. 2014 Oct;21(10):3342-7. doi: 10.1245/s10434-014-3921-1. Epub 2014 Jul 22.

    Related:

    Comments from NSGC Discussion Forum Cancer SIG

    Subject: Article Request

    • A multilevel model of postmenopausal breast cancer incidence.
    • Hiatt RA, Porco TC, Liu F, Balke K, Balmain A, Barlow J, Braithwaite D, Diez-Roux AV, Kushi LH, Moasser MM, Werb Z, Windham GC, Rehkopf DH.
    • Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2078-92. doi: 10.1158/1055-9965.EPI-14-0403. Epub 2014 Jul 13.
    • Pioneering geneticist Mary-Claire King receives the 2014 Lasker~Koshland Special Achievement Award in Medical Science.
    • Hurst JH.
    • J Clin Invest. 2014 Oct;124(10):4148-51. doi: 10.1172/JCI78507. Epub 2014 Sep 8.
    • Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.
    • de Vree PJ, de Wit E, Yilmaz M, van de Heijning M, Klous P, Verstegen MJ, Wan Y, Teunissen H, Krijger PH, Geeven G, Eijk PP, Sie D, Ylstra B, Hulsman LO, van Dooren MF, van Zutven LJ, van den Ouweland A, Verbeek S, van Dijk KW, Cornelissen M, Das AT, Berkhout B, Sikkema-Raddatz B, van den Berg E, van der Vlies P, Weening D, den Dunnen JT, Matusiak M, Lamkanfi M, Ligtenberg MJ, ter Brugge P, Jonkers J, Foekens JA, Martens JW, van der Luijt R, van Amstel HK, van Min M, Splinter E, de Laat W.
    • Nat Biotechnol. 2014 Oct;32(10):1019-25. doi: 10.1038/nbt.2959. Epub 2014 Aug 17.
    • Benefits, Beneficence, and Bending Ethics: Questionable Billing Practices for Multigene Panels?
    • Robert Resta.
    • The DNA Exchange, 2014 Sep 28.
    • Insurance Coverage Could Be Obstacle to Genetic Testing That Could Warn of Breast Cancer Risk.
    • ABC Digital.
    • East Idaho News.com, 2014 Sep 19.
    • Study Finds Counseling, Insurance Coverage, and Personal Preference Impact Decision to Pursue BRCA Testing.
    • Christina Izzo.
    • Oncology Nursing News, 2014 Sep 19.
    • Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing.
    • Tessereau C, Lesecque Y, Monnet N, Buisson M, Barjhoux L, Léoné M, Feng B, Goldgar DE, Sinilnikova OM, Mousset S, Duret L, Mazoyer S.
    • Nucleic Acids Res. 2014 Aug;42(14):9121-30. doi: 10.1093/nar/gku639. Epub 2014 Jul 17.
    • From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo.
    • Luyeye Mvila G, Postema S, Marchal G, Van Limbergen E, Verdonck F, Matthijs G, Devriendt K, Michils G, Van Ongeval C.
    • BMC Public Health. 2014 Jul 28;14:759. doi: 10.1186/1471-2458-14-759.
    • Absence of BRCA/FMR1 Correlations in Women with Ovarian Cancers.
    • Gleicher N, McAlpine JN, Gilks CB, Kushnir VA, Lee HJ, Wu YG, Lazzaroni-Tealdi E, Barad DH.
    • PLoS One. 2014 Jul 18;9(7):e102370. doi: 10.1371/journal.pone.0102370. eCollection 2014.
    • Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium.
    • Colombo M, Blok MJ, Whiley P, Santamariña M, Gutiérrez-Enríquez S, Romero A, Garre P, Becker A, Smith LD, De Vecchi G, Brandão RD, Tserpelis D, Brown M, Blanco A, Bonache S, Menéndez M, Houdayer C, Foglia C, Fackenthal JD, Baralle D, Wappenschmidt B; kConFaB Investigators, Díaz-Rubio E, Caldés T, Walker L, Díez O, Vega A, Spurdle AB, Radice P, De La Hoya M.
    • Hum Mol Genet. 2014 Jul 15;23(14):3666-80. doi: 10.1093/hmg/ddu075. Epub 2014 Feb 25.
    • Rapid evolution of BRCA1 and BRCA2 in humans and other primates.
    • Lou DI, McBee RM, Le UQ, Stone AC, Wilkerson GK, Demogines AM, Sawyer SL.
    • BMC Evol Biol. 2014 Jul 11;14:155. doi: 10.1186/1471-2148-14-155.
    • BRCA1 Haploinsufficiency Leads to Altered Expression of Genes Involved in Cellular Proliferation and Development.
    • Feilotter HE, Michel C, Uy P, Bathurst L, Davey S.
    • PLoS One. 2014 Jun 20;9(6):e100068. doi: 10.1371/journal.pone.0100068. eCollection 2014.
    • The Truth about Public Genetic Databases.
    • [No author given]
    • Yale Cancer Genetic Counseling, 2014 Jun 16.
    • Knowing BRCA Changed My Life.
    • Debbie Wasserman Schultz.
    • The Topic Is Cancer, CDC's Division of Cancer Prevention and Control, 2014 Jun 10.
    • Cancer-gene data sharing boosted.
    • Hayden EC.
    • Nature. 2014 Jun 10;510(7504):198. doi: 10.1038/510198a.
    • Don’t Deny our Active Military Life-Saving Genetic Services.
    • [No author given]
    • Yale Cancer Genetic Counseling, 2014 Jun 6.
    • Lessons From the Woman Who Discovered the BRCA Cancer Gene.
    • Alice Park.
    • Time.com, 2014 Jun 2.
    • Cigna Corporation’s Genetic Testing and Counseling Program.
    • Sara Gilvary.
    • Coding Corner, Perspectives in Genetic Counseling, Volume 36, Number 2, p. 15, 2014 Qtr 2.
    • Counsyl expands affordable genetic screening to BRCA1/2 testing.
    • Philippa Brice.
    • PHG Foundation, 2014 May 21.
    • Choosing a BRCA Genetic Testing Laboratory: A Patient-Centric and Ethical Call to Action for Clinicians and Payers.
    • Ellen T. Matloff, Rachel E. Barnett, Robert Nussbaum.
    • AJMC.com Managed Markets Network, 2014 May 15.
    • Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria.
    • Marshall PA, Adebamowo CA, Adeyemo AA, Ogundiran TO, Strenski T, Zhou J, Rotimi CN.
    • BMC Med Ethics. 2014 May 13;15:38. doi: 10.1186/1472-6939-15-38.
    • Counsyl gets funding for new genetic tests.
    • Stephanie M. Lee.
    • SFGate, 2014 May 8.
    • Stakeholder consultation insights on the future of genomics at the clinical-public health interface.
    • Modell SM, Kardia SL2, Citrin T3.
    • Transl Res. 2014 May;163(5):466-77. doi: 10.1016/j.trsl.2013.12.007. Epub 2013 Dec 25.
    • Review
    • Breast cancer. A race still unfinished. Introduction.
    • Kiberstis P, Roberts L.
    • Science. 2014 Mar 28;343(6178):1451. doi: 10.1126/science.343.6178.1451.
    • "The Race" to Clone BRCA1.
    • King MC.
    • Science. 2014 Mar 28;343(6178):1462-5. doi: 10.1126/science.1251900.
    • Editorial / Commentary
    • Genetic Testing Lab Position Statement.
    • [No author given]
    • Yale Cancer Genetic Counseling, 2014 Feb 24.
    • Do BRCA1/2 mutations and low FMR1 alleles interact or not?
    • Gleicher N, Weghofer A, Barad DH.
    • Eur J Hum Genet. 2014 Feb;22(2):155-6. doi: 10.1038/ejhg.2013.213. Epub 2013 Sep 25.

    Related:

    The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutations.

    • BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study.
    • Dagan E, Cohen Y, Mory A, Adir V, Borochowitz Z, Raanani H, Kurolap A, Melikhan-Revzin S, Meirow D, Gershoni-Baruch R.
    • Eur J Hum Genet. 2014 Feb;22(2):277-9. doi: 10.1038/ejhg.2013.281. Epub 2013 Nov 27.
    • BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study.
    • Dagan E, Cohen Y, Mory A, Adir V, Borochowitz Z, Raanani H, Kurolap A, Melikhan-Revzin S, Meirow D, Gershoni-Baruch R.
    • Eur J Hum Genet. 2014 Feb;22(2):277-9. doi: 10.1038/ejhg.2013.281. Epub 2013 Nov 27.
    • The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutations.
    • Ricci MT, Pennese L, Gismondi V, Perfumo C, Grasso M, Gennaro E, Bruzzi P, Varesco L.
    • Eur J Hum Genet. 2014 Feb;22(2):280-2. doi: 10.1038/ejhg.2013.193. Epub 2013 Sep 25.

    Related:

    Comment:

    Do BRCA1/2 mutations and low FMR1 alleles interact or not?

    • Genomic analysis of primordial dwarfism reveals novel disease genes.
    • Shaheen R, Faqeih E, Ansari S, Abdel-Salam G, Al-Hassnan ZN, Al-Shidi T, Alomar R, Sogaty S, Alkuraya FS.
    • Genome Res. 2014 Feb;24(2):291-9. doi: 10.1101/gr.160572.113. Epub 2014 Jan 3.
    • Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling.
    • Meyer S, Tischkowitz M, Chandler K, Gillespie A, Birch JM, Evans DG.
    • J Med Genet. 2014 Feb;51(2):71-5. doi: 10.1136/jmedgenet-2013-101642. Epub 2013 Nov 20.
    • Did we need a new Angelina Jolie to discuss about prophylactic surgery for colon cancer because of Mister Lynch's silence?
    • Pocard M.
    • J Visc Surg. 2014 Feb;151(1):1-2. doi: 10.1016/j.jviscsurg.2013.11.001. Epub 2013 Dec 25.
    • Biography, Editorial
    • Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models.
    • Engelhardt EG, Garvelink MM, de Haes JH, van der Hoeven JJ, Smets EM, Pieterse AH, Stiggelbout AM.
    • J Clin Oncol. 2014 Jan 20;32(3):238-50. doi: 10.1200/JCO.2013.50.3417. Epub 2013 Dec 16.
    • Review
    • A Two-Stage Association Study Suggests BRAP as a Susceptibility Gene for Schizophrenia.
    • Zhang F, Liu C, Xu Y, Qi G, Yuan G, Cheng Z, Wang J, Wang G, Wang Z, Zhu W, Zhou Z, Zhao X, Tian L, Jin C, Yuan J, Zhang G, Chen Y, Wang L, Lu T, Yan H, Ruan Y, Yue W, Zhang D.
    • PLoS One. 2014 Jan 15;9(1):e86037. doi: 10.1371/journal.pone.0086037. eCollection 2014.
    • Medicare Slashes Reimbursement for BRCA Gene Testing.
    • Roxanne Nelson.
    • Medscape Medical News > Oncology, 2014 Jan 3.
    • CMS Cuts Reimbursement for BRCA1/2 Testing by 49 Percent; Analyst Downgrades Myriad Shares.
    • [No author given]
    • Yale Cancer Genetic Counseling. 2014 Jan 2.
    • Free the data.
    • Lambertson K, Terry SF.
    • Genet Test Mol Biomarkers. 2014 Jan;18(1):1-2. doi: 10.1089/gtmb.2014.1551.
    • Editorial / Commentary
    • Influence of estrogen and variations at the BRCA1 promoter region on transcription and translation.
    • Fernandes LR, Costa EC, Vargas FR, Moreira MA.
    • Mol Biol Rep. 2014 Jan;41(1):489-95. doi: 10.1007/s11033-013-2884-9. Epub 2013 Dec 1.
    • Mapping Jewish Identities: Migratory Histories and the Transnational Re-Framing of ‘Ashkenazi BRCA Mutations’ in the UK and Brazil.
    • Mozersky J, Gibbon S.
    • In: Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Oxon (UK): Routledge; 2014. Gibbon S, Joseph G, Mozersky J, zur Nieden A, Palfner S, editors. Wellcome Trust–Funded Monographs and Book Chapters.
    • Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.
    • Zghair AN, Sharma R, Sharma AK.
    • Curr Pharm Biotechnol. 2014;15(12):1113-24.
    • Review
    • Medicare slashes payment for BRCA test.
    • McCarthy M.
    • BMJ. 2013 Dec 31;347:f7709. doi: 10.1136/bmj.f7709.
    • News
    • Network-based analysis of omics with multi-objective optimization.
    • Mosca E, Milanesi L.
    • Mol Biosyst. 2013 Dec 29;9(12):2971-80. doi: 10.1039/c3mb70327d. Epub 2013 Oct 14.
    • A Myriad of Choices: How the Supreme Court’s Decision Has Affected Clinical Practice.
    • Kristen Hanson.
    • Perspectives in Genetic Counseling. 35(4):6-7. 2013 Qtr 4.
    • Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers.
    • Pal T, Vadaparampil S, Kim J, Xu Y, Friedman S, Narod SA, Metcalfe K.
    • Fam Cancer. 2013 Dec;12(4):615-9. doi: 10.1007/s10689-013-9624-0.
    • Supreme Court Ruling Broadens BRCA Testing Options.
    • Azvolinsky A.
    • J Natl Cancer Inst. 2013 Nov 20;105(22):1671-2. doi: 10.1093/jnci/djt342. Epub 2013 Nov 6.
    • My Cancer Story, My Genes, My Information.
    • Joanna Rudnick.
    • Huffington Post. The Blog. 2013 Nov 19.
    • Quest to offer genetic test for breast cancer risk.
    • Bill Berkrot.
    • Yahoo! News. Reuters. 2013 Oct 15.
    • Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
    • Weisstock CR, Rajapakshe R, Bitgood C, McAvoy S, Gordon PB, Coldman AJ, Parker BA, Wilson C.
    • Cancer Prev Res (Phila). 2013 Oct;6(10):1084-92. doi: 10.1158/1940-6207.CAPR-13-0027. Epub 2013 Aug 20.
    • 'The Angelina Jolie Effect' symposium offers inspiration, information.
    • [No author given]
    • Yale Cancer Genetic Counseling. 2013 Sep 26.
    • Has Myriad Learned Their Lesson?
    • Niki Lovick, Michelle Ernst.
    • Yale Cancer Genetic Counseling. 2013 Sep 11.
    • Evidence is evidence: an interview with Mary-Claire King. Interviewed by Jane Gitschier.
    • King MC.
    • PLoS Genet. [2013 Sep;]9(9):e1003828. doi: 10.1371/journal.pgen.1003828. Epub 2013 Sep 26.
    • Allocation of work activities in a comprehensive cancer genetics program.
    • Mahon SM.
    • Clin J Oncol Nurs. 2013 Aug 1;17(4):397-404. doi: 10.1188/13.CJON.397-404.

    Related:

    Comments on NSGC Discussion Forum Cancer SIG

    Subject: Cancer GC cost-benefit/downstream revenue analysis

    • Mary-Claire King: taking genes beyond the lab.
    • Watts G.
    • Lancet. 2013 Jul 13;382(9887):119. doi: 10.1016/S0140-6736(13)61551-2.
    • COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration.
    • COMPLEXO, Southey MC, Park DJ, Nguyen-Dumont T, Campbell I, Thompson E, Trainer AH, Chenevix-Trench G, Simard J, Dumont M, Soucy P, Thomassen M, Jønson L, Pedersen IS, Hansen TV, Nevanlinna H, Khan S, Sinilnikova O, Mazoyer S, Lesueur F, Damiola F, Schmutzler R, Meindl A, Hahnen E, Dufault MR, Chris Chan T, Kwong A, Barkardóttir R, Radice P, Peterlongo P, Devilee P, Hilbers F, Benitez J, Kvist A, Törngren T, Easton D, Hunter D, Lindstrom S, Kraft P, Zheng W, Gao YT, Long J, Ramus S, Feng BJ, Weitzel JN, Nathanson K, Offit K, Joseph V, Robson M, Schrader K, Wang S, Kim YC, Lynch H, Snyder C, Tavtigian S, Neuhausen S, Couch FJ, Goldgar DE.
    • Breast Cancer Res. 2013 Jun 21;15(3):402. doi: 10.1186/bcr3434.
    • Myriad BRCA Patents Nixed: What Happens Next?
    • Roxanne Nelson.
    • Medscape Medical News. Oncology. 2013 Jun 21.
    • Lou Gehrig, Angelina Jolie, and cancer genetics.
    • Burstein HJ.
    • J Natl Compr Canc Netw. 2013 Jun 1;11(6):631-2.
    • Editorial
    • Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.
    • So D, Joly Y.
    • Curr Pharmacogenomics Person Med. 2013 Jun;11(2):98-109.
    • The next controversy in genetic testing: clinical data as trade secrets?
    • Cook-Deegan R, Conley JM, Evans JP, Vorhaus D.
    • Eur J Hum Genet. 2013 Jun;21(6):585-8. doi: 10.1038/ejhg.2012.217. Epub 2012 Nov 14.

    Related:

    News

    Genetics testing firm is accused of “hiding vital breast cancer data”

    News blog: Policy paper: Myriad turns cancer genetic data into trade secrets (Nature.com)

    • Incorporating genomics into breast and prostate cancer screening: assessing the implications.
    • Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, Hall P, Pharoah P, Burton H.
    • Genet Med. 2013 Jun;15(6):423-32. doi: 10.1038/gim.2012.167. Epub 2013 Feb 14.
    • The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer Study.
    • Australian Ovarian Cancer Study Group, Hallowell N, Alsop K, Gleeson M, Crook A, Plunkett L, Bowtell D, Mitchell G, Young MA.
    • Genet Med. 2013 Jun;15(6):458-65. doi: 10.1038/gim.2012.154. Epub 2013 Feb 28.
    • Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.
    • Soto AM, Brisken C, Schaeberle C, Sonnenschein C.
    • J Mammary Gland Biol Neoplasia. 2013 Jun;18(2):199-208. doi: 10.1007/s10911-013-9293-5. Epub 2013 May 24.
    • BRCA Choices Not Affordable for Many US Women.
    • Roxanne Nelson.
    • Medscape Medical News. Oncology. 2013 May 23.
    • Angelina Jolie's double mastectomy and the question of who owns our genes.
    • Hurley R.
    • BMJ. 2013 May 22;346:f3340. doi: 10.1136/bmj.f3340.
    • Editorial / Commentary
    • Breast Cancer Genetic Testing Gets Covered by Health Care Reform.
    • Rachael Rettner.
    • Yahoo. MyHealthNewsDaily. 2013 Mar 6.
    • BRCA1 and Its Network of Interacting Partners.
    • Christou CM, Kyriacou K.
    • Biology (Basel). 2013 Jan 2;2(1):40-63. doi: 10.3390/biology2010040.
    • BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis.
    • Teoh H, Quan A, Creighton AK, Annie Bang KW, Singh KK, Shukla PC, Gupta N, Pan Y, Lovren F, Leong-Poi H, Al-Omran M, Verma S.
    • Gene Ther. 2013 Jan;20(1):51-61. doi: 10.1038/gt.2011.214. Epub 2012 Jan 19.
    • Public Health Action in Genomics Is Now Needed beyond Newborn Screening.
    • Bowen MS, Kolor K, Dotson WD, Ned RM, Khoury MJ.
    • Public Health Genomics. [2012 Nov;]15(6):327-34. doi: 10.1159/000341889. Epub 2012 Sep 11.
    • Legal liability and the uncertain nature of risk prediction: the case of breast cancer risk prediction models.
    • Black L, Knoppers BM, Avard D, Simard J.
    • Public Health Genomics. [2012 Nov;]15(6):335-40. doi: 10.1159/000342138. Epub 2012 Sep 12.
    • A Working Meeting and an Action Plan to Save Lives Now.
    • Scott Bowen, Karen Greendale.
    • Genomics and Health Impact Blog, CDC, 2012 Oct 3.
    • [Women with high risk of breast cancer.More bright spots than shadows and many dark spots].
    • Vázquez Caruncho M.
    • Radiologia. 2012 Sep-Oct;54(5):462-4. doi: 10.1016/j.rx.2011.10.004. Epub 2012 Jan 28.
    • How genetic variant libraries effectively extend gene testing patents: implications for intellectual property and good clinical care.
    • McElligott S, Field RI, Bristol-Demeter M, Domchek SM, Asch DA.
    • J Clin Oncol. 2012 Aug 20;30(24):2943-5. Epub 2012 Jul 16.
    • Can a simple blood test really predict breast cancer?
    • McCartney M.
    • BMJ. 2012 May 15;344:e3374. doi: 10.1136/bmj.e3374.
    • News
    • Clinical software development for the Web: lessons learned from the BOADICEA project.
    • Cunningham AP, Antoniou AC, Easton DF.
    • BMC Med Inform Decis Mak. 2012 Apr 10;12:30. doi: 10.1186/1472-6947-12-30.
    • Using core public health functions to promote BRCA best practices among health plans.
    • Duquette D, Lewis K, McLosky J, Bach J.
    • Public Health Genomics. [2012 Jan;]15(2):92-7. doi: 10.1159/000334267. Epub 2011 Dec 20.